HCPLive Network

Pediatric Lupus Severity Varies With Ethnicity

 
TUESDAY, Jan. 22 (HealthDay News) -- While Canadian children with systemic lupus erythematosus (SLE) differ in disease characteristics and severity by ethnicity, treatment, disease activity, and irreversible organ damage are similar across ethnic groups, according to a study published in the January issue of Arthritis Care & Research.

Deborah M. Levy, M.D., from the Hospital for Sick Children in Toronto, and colleagues analyzed ethnicity, sociodemographics, and disease characteristics in 213 Canadian children with childhood-onset SLE. The ethnic composition was 31 percent white, 30 percent Asian, 15 percent South Asian, 10 percent black, 4 percent Latino/Hispanic, 4 percent Aboriginal, and 3 percent Arab/Middle Eastern.

The researchers found that disease manifestations (malar rash, arthritis, serositis, renal disease), autoantibody profiles, and severity of disease expression differed by ethnicity. Only 20 percent of whites had severe disease, compared with 51 percent of Asian patients and 41 percent of black patients. However, disease activity indices, irreversible organ damage, and treatment (76 percent receiving prednisone, 86 percent receiving antimalarials, and 56 percent requiring additional immunosuppressants) were similar across ethnicities.

"Canadian childhood-onset SLE patients reflect our multiethnic population, with differences in disease manifestations, autoantibody profiles, and severity of disease expression by ethnicity," Levy and colleagues write. "We did not observe differences in the measured outcomes of treatment, disease activity, and irreversible organ damage. These findings would suggest that universal access to health care in Canada is an important determinant of positive outcomes in childhood-onset SLE."
 

Abstract
Full Text

Copyright © 2013 HealthDay. All rights reserved.
 
 

Further Reading
Children born to mothers diagnosed with systemic lupus erythematosus (SLE) may be twice as likely to develop autism as those whose mothers don’t have the chronic autoimmune disease.
A new retrospective study suggests that patients with autoimmune disorders should be monitored for epilepsy, and vice versa.
Dietary vitamin D intake during adolescence does not appear to be associated with the risk of adult-onset rheumatoid arthritis or systemic lupus erythematosus, according to research published in the December issue of Arthritis Care & Research.
Lady Gaga announced that she recently tested borderline positive for lupus. Dr. Pullen talks about lupus tests, false positives, and diagnostic uncertainty.
Patient age, hypertension, and corticosteroid use are the most important predictors of the cumulative organ damage that occurs in patients with systemic lupus erythematosus, according to research published in the December issue of Arthritis & Rheumatism.
Belimumab is safe for long-term administration in the treatment of systemic lupus erythematosus, according to a study published in the October issue of Arthritis & Rheumatism.
Bonus coverage of study results announced at ACR/ARHP 2010 showing the effects of statins on cardiovascular disease risk in children with lupus.
More Reading